- Environmental Protection Masks, Nano Masks, N95, Pandemic Protection Packs^TM, Germicides, and more!

Protect youreself from Avian Flu, SARS, Tuberculosis, and other AirBorne Diseases...

Swine Flu / Bird Flu / Avian Influenza Prevention and Protection Products... PANDEMIC FLU PROTECTION AND PREVENTION According to the CDC:

Recommendations for Swine Flu & Avian Influenza include:
Use of a fit-tested respirator, at least as protective as a National Institute of Occupational Safety and Health (NIOSH)-approved N-95 filtering facepiece (i.e., disposable) respirator, when entering the room. PLEASE NOTE THAT EXPRESS SHIPPING IS NOT GUARANTEED DURING ELEVATED THREAT/ELEVATED DEMAND PERIODS - YOU MAY ALWAYS CALL US TO ORDER BY PHONE.

Click for... Nano Masks N95 Masks Pandemic Protection Packs^TM Germicides

OUR RECOMMENDATIONS...

PREVENTATIVE PRODUCTS: Masks, Barriers, and filters for Airborne Pathogen Protection

Personal Protection Kits

PP-106 Personal Protection Kit

Suggested Retail**$~~9.99~~

Reduce your biohazard risks with this basic personal protection kit. Includes an N95 rated mask, exam quality gloves to protect your hands, and germicidal wipes to disinfect surfaces.

Pandemic Preparedness Pack™ - for 1 person
SKU: DIX-AVIANKIT1

Pandemic Preparedness Pack™ / Protective Bird Flu Kit

This kit has everything you need to protect yourself from possible infection when entering an area with known contamination.

Includes:

(5) Pyramex 1870 N95 Respirator Mask
(1) Safety Goggles
(1) Disposable White Coverall w/ Elasticized hood, wrist, and boot
(1) 2 pair of High risk Nitryl Gloves
(1) Insta-Clean Hand sanitizer
(6) Antimicrobial hand wipes
(1) Box of 10 Alcohol Prep Wipes
(5) Blue Elasticized Shoe Covers
(5) Blue Elasticized Head Caps
(1) Water Resistant Plastic Bag

Suggested Retail $~~34.95~~

Pandemic/ Flu Preparedness Kits

5 DAY Individual Pandemic / Infection Control Kit

SKU: 6086 SOLD OUT - 2 WEEK BACKORDER IF YOU STILL WISH TO ORDER

This Individual Pandemic/Infection Control Kit contains
products suggested by the CDC & World Health Organization when dealing with or preparing for the pandemic flu virus.

5-Day Kit Contents:
10 ea. N95 Flat Fold Respirators
10 pr. Nitrile Gloves
10 ea. Antibacterial Hand Wipes
1 Bottle Hand Sanitizer 0.75 fl oz. (22 mil)

DO NOT PAY $~~14.95~~

Click on the button above to Save! Buy 20 at Wholesale Direct Pricing...
Just $9.99 each

N95 Respirator Mask - 20 per box
SKU: M9410-FM-20

N95 Particulate respirator mask, Duck Bill style, 20 per box

Used for the effective protection against the transmission of airborne pathogens. Contains soft hypoallergenic inner facial lining, and elastic retention band for easy application.

Suggested Retail $~~68.95~~

BioZide™ antiseptic bio hand cleaner gel, 4 oz. plastic bottle, Our freshly scented antiseptic bio hand cleaner kills bacteria, fights infection, and reduces the likelihood of disease transmission between persons. Contains aloe vera. Active ingredient: Ethyl Alcohol (denatured) 66.5%.

Antiseptic Bio Hand Cleansing Gel, 4 oz. - 1 each
SKU: M927

BioZide™ antiseptic bio hand cleaner gel, 4 oz. plastic bottle, 1 ea. or case of 24

Our freshly scented antiseptic bio hand cleaner kills bacteria, fights infection, and reduces the likelihood of disease transmission between persons. Contains aloe vera. Active ingredient: Ethyl Alcohol (denatured) 66.5%.

Suggested Retail $~~3.50~~

SaniZide Plus germicidal solution, 1 gallon
SKU: M-922

Environmental surface germicidal solution, 1 gallon refill - 1 each

Use our one step, ready-to-use (alcohol free) germicidal solution by SaniZide Plus in critical care areas where controlling cross-contamination is vital. Proven effective against a wide variety of bacterial and viral pathogens including Staph, Salmonella, Herpes Simplex Type II and the human immuno-deficiency virus Type I (HIV-1) associated with AIDS all in under ten minutes. Active Ingredients: n-Alkyl Dimethyl Ethybenzyl Ammonium Chloride, n-Alkyl Dimethyl Benzyl Ammonium Chloride, Isopropyl Alcohol.

Suggested Retail $~~42.69~~

SaniZide Plus germicidal solution, 16 oz.
SKU: M-920

Environmental surface germicidal solution, 16 oz. bottle w/trigger - 1 each

Suggested Retail $~~14.99~~

SaniZide Plus germicidal solution, 2 oz.
SKU: M-919

Environmental surface germicidal solution, 2 oz. bottle w/pump- 1 each

Suggested Retail $~~5.59~~

Highly effective in high-risk situations, Super Sani-Cloth destroys more types of microorganisms than any other wipe. It's the only wipe proven effective against VRE, MRSA and E-Coli, and no other disinfectant kills Tuberculosis, HIV and Herpes viruses, or such a wide range of gram positive and gram negative bacteria faster than Super Sani-Cloth. Convenient and easy to use, it virtually eliminates airborne hazards associated with sprays. Allows a large area to be disinfected in one easy step. Complies with OSHA guidelines. Active Ingredients: n-Alkyl Dimethyl Ethybenzyl Ammonium Chloride, n-Alkyl Dimethyl Benzyl Ammonium Chloride, Isopropyl Alcohol.

Germicidal disposable wipe
SKU: M-905

5"x8" Germicidal (kills germs) wipe, covers 7.5 sq. ft. - 50 per box

Highly effective in high-risk situations, Super Sani-Cloth destroys more types of microorganisms than any other wipe. It's the only wipe proven effective against VRE, MRSA and E-Coli, and no other disinfectant kills Tuberculosis, HIV and Herpes viruses, or such a wide range of gram positive and gram negative bacteria faster than Super Sani-Cloth. Convenient and easy to use, it virtually eliminates airborne hazards associated with sprays. Allows a large area to be disinfected in one easy step. Complies with OSHA guidelines. Active Ingredients: n-Alkyl Dimethyl Ethybenzyl Ammonium Chloride, n-Alkyl Dimethyl Benzyl Ammonium Chloride, Isopropyl Alcohol.

Suggested Retail $~~22.09~~

Our Antimicrobial wipes by Safetec contain a broad spectrum germ-killing agent to clean and sanitize the hands. Active ingredients: Chloroxylenol (PCMX) 0.5%, Ethyl Alcohol 40.0% and Aloe.

Personal Antimicrobial Wipe
SKU: M-928 / M928

5"x8" P.A.W.S. antimicrobial (kills germs) wipe - 100 per box

Our Antimicrobial wipes by Safetec contain a broad spectrum germ-killing agent to clean and sanitize the hands. Active ingredients: Chloroxylenol (PCMX) 0.5%, Ethyl Alcohol 40.0% and Aloe.

Do Not Pay Suggested Retail Price of $~~24.77~~

Why Pay Retail?™ Discount Online Price, Just $15.66 - 40% off

Wholesale Direct Case Pricing...
Just $13.24 each - 50% off

PLUS...

Germicidal Solution, Germicidal Wipes, Barrier Wipes, Antimicrobial Wipes, Disinfectant & Deodorizer , SBS Sanitizing Gel,

First Aid Home Page Kit Buyer's Guide First Aid Guide Links Contact Us Help!

888-228-6694 CALL US TOLL FREE!

Your source for Airborne Pathogen Masks, Avian Flu prevention, Protection from SARS Virus, Avian Flu and other air born pathogens, N95 products and supplies - Masks, Face Shields, and Filters - Wholesale to the Public Manufacturer Direct Safety Product Sales since 1993

MORE INFORMATION FROM THE CDC on Avian Flu Prevention & Protection:

Recommendations for Avian Influenza include:
Use of a fit-tested respirator, at least as protective as a National Institute of Occupational Safety and Health (NIOSH)-approved N-95 filtering facepiece (i.e., disposable) respirator, when entering the room.

How are avian, pandemic, and seasonal flu different?
Avian flu is caused by avian influenza viruses, which occur naturally among birds.
Pandemic flu is flu that causes a global outbreak, or pandemic, of serious illness that spreads easily from person to person. Currently there is no pandemic flu.
Seasonal flu is a contagious respiratory illness caused by influenza viruses.

What You Should Know

Key Facts Dec 28
Infection in Humans

Questions & Answers
WHO Avian Flu FAQ
(From World Health Organization)

Specific Topics

Outbreaks
North America, Asia & Europe Jan 5 , Bird Embargo Dec 29, Quarantine Executive Order…

Information for Specific Groups

Interim Recommendations for Infection Control in Health-Care Facilities Caring for Patients with Known or Suspected Avian Influenza

PDF formatted for print
(119 KB/3 pages)
Prevention of Avian Flu
Infection Control in Health-Care Facilities
Avian Flu Vaccines

Note: CDC is revising its interim guidance for infection control precautions for avian influenza. The revised recommendations will be posted on this website as soon as they are finalized.

Objective

This document provides interim guidance for protection of health-care workers involved in the care of patients in the United States with known or suspected avian influenza. Depending upon where avian influenza is active in the world, such patients may be recently returning travelers entering U.S. health-care facilities or individuals who have had close contact with domestic poultry infected with avian influenza in the United States. For information regarding the clinical and epidemiologic criteria to be used in screening patients for possible avian influenza, see the “Update on Influenza A(H5N1) and SARS: Interim Recommendations for Enhanced U.S. Surveillance, Testing, and Infection Control” and “Interim Recommendations for Persons with Possible Exposure to Avian Influenza During Outbreaks Among Poultry in the United States .”

Background

Influenza viruses that infect primarily birds are called “avian influenza viruses.” These type A influenza viruses are genetically distinguishable from influenza viruses that usually infect people. There are many subtypes of avian influenza A viruses, including H7 and H5. Avian influenza viruses can be distinguished as “low pathogenic” and “highly pathogenic” forms based on genetic features of the virus and the severity of the illness they cause in poultry.

Avian influenza viruses do not usually infect humans; however, several instances of human infections and outbreaks of avian influenza have been reported since 1997 (for more information, see “ Basic Information About Avian Influenza” ). In 2003, influenza A (H7N7) infections occurred in the Netherlands among persons who handled infected poultry and among their families during an outbreak of avian flu among poultry. More than 80 cases of H7N7 illness were confirmed by testing (the symptoms were mostly confined to eye infections, with some respiratory symptoms), and one patient died (a veterinarian who had visited an H7N7 influenza-affected farm). Although there was evidence of limited person-to-person spread of infection, sustained human-to-human transmission did not occur in this or other outbreaks of avian influenza. It is believed that most cases of avian influenza infection in humans have resulted from contact with infected poultry or contaminated surfaces. However, other means of transmission are also possible, such as the virus becoming aerosolized and landing on exposed surfaces of the mouth, nose, or eyes, or being inhaled into the lungs.

Infection and disease in people caused by highly pathogenic avian influenza H5N1 infection have been identified recently in Vietnam and Thailand. On February 1, 2004, the World Health Organization (WHO) reported that laboratory test results had confirmed two fatal cases of human H5N1 infection in Vietnam in which human-to-human transmission may have occurred. The cases occurred in two sisters who were part of a cluster of four cases of severe respiratory illness in a single family. According to WHO, a detailed investigation of this cluster concluded that limited human-to-human transmission was one possible explanation, but direct poultry-to-human transmission could not be ruled out.

The following interim recommendations are based on what are deemed optimal precautions for protecting individuals involved in the care of patients with highly pathogenic avian influenza from illness and for reducing the risk of viral reassortment (i.e., mixing of genes from human and avian viruses). The ability of low pathogenic avian influenza viruses to cause infection and serious disease is less well established, but appears to be lower than that of highly pathogenic viruses based on available information. Nonetheless, it is considered prudent to take all possible precautions to the extent feasible when caring for patients with known or possible avian influenza.

Rationale for Enhanced Precautions

Human influenza is thought to transmit primarily via large respiratory droplets. Standard Precautions plus Droplet Precautions are recommended for the care of patients infected with human influenza. However, given the uncertainty about the exact modes by which avian influenza may first transmit between humans additional precautions for health-care workers involved in the care of patients with documented or suspected avian influenza may be prudent. The rationale for the use of additional precautions for avian influenza as compared with human influenza include the following:

The risk of serious disease and increased mortality from highly pathogenic avian influenza may be significantly higher than from infection by human influenza viruses.
Each human infection represents an important opportunity for avian influenza to further adapt to humans and gain the ability to transmit more easily among people.
Although rare, human-to-human transmission of avian influenza may be associated with the possible emergence of a pandemic strain.

Recommendations for Avian Influenza

All patients who present to a health-care setting with fever and respiratory symptoms should be managed according to recommendations for Respiratory Hygiene and Cough Etiquette and questioned regarding their recent travel history.

Patients with a history of travel within 10 days to a country with avian influenza activity and are hospitalized with a severe febrile respiratory illness, or are otherwise under evaluation for avian influenza, should be managed using isolation precautions identical to those recommended for patients with known Severe Acute Respiratory Syndrome (SARS). These include:

Standard Precautions
- Pay careful attention to hand hygiene before and after all patient contact or contact with items potentially contaminated with respiratory secretions.
Contact Precautions
- Use gloves and gown for all patient contact.
- Use dedicated equipment such as stethoscopes, disposable blood pressure cuffs, disposable thermometers, etc.
Eye protection (i.e., goggles or face shields)
- Wear when within 3 feet of the patient.
Airborne Precautions
- Place the patient in an airborne isolation room (AIR). Such rooms should have monitored negative air pressure in relation to corridor, with 6 to 12 air changes per hour (ACH), and exhaust air directly outside or have recirculated air filtered by a high efficiency particulate air (HEPA) filter. If an AIR is unavailable, contact the health-care facility engineer to assist or use portable HEPA filters (see Environmental Infection Control Guidelines) to augment the number of ACH.
- Use a fit-tested respirator, at least as protective as a National Institute of Occupational Safety and Health (NIOSH)-approved N-95 filtering facepiece (i.e., disposable) respirator, when entering the room.

For additional information regarding these and other health-care isolation precautions, see the Guidelines for Isolation Precautions in Hospitals. These precautions should be continued for 14 days after onset of symptoms or until either an alternative diagnosis is established or diagnostic test results indicate that the patient is not infected with influenza A virus. Patients managed as outpatients or hospitalized patients discharged before 14 days with suspected avian influenza should be isolated in the home setting on the basis of principles outlined for the home isolation of SARS patients (see http://www.cdc.gov/ncidod/sars/guidance/i/pdf/i.pdf).

Vaccination of Health-Care Workers against Human Influenza

health-care workers involved in the care of patients with documented or suspected avian influenza should be vaccinated with the most recent seasonal human influenza vaccine. In addition to providing protection against the predominant circulating influenza strain, this measure is intended to reduce the likelihood of a health-care worker’s being co-infected with human and avian strains, where genetic rearrangement could take place, leading to the emergence of potential pandemic strain.

Surveillance and Monitoring of Health-Care Workers

Instruct health-care workers to be vigilant for the development of fever, respiratory symptoms, and/or conjunctivitis (i.e., eye infections) for 1 week after last exposure to avian influenza-infected patients.
Health-care workers who become ill should seek medical care and, prior to arrival, notify their health-care provider that they may have been exposed to avian influenza. In addition, employees should notify occupational health and infection control personnel at their facility.
With the exception of visiting a health-care provider, health-care workers who become ill should be advised to stay home until 24 hours after resolution of fever, unless an alternative diagnosis is established or diagnostic tests are negative for influenza A virus.
While at home, ill persons should practice good Respiratory Hygiene and Cough Etiquette to lower the risk of transmission of virus to others.

Respirators should be used in the context of a complete respiratory protection program as required by the Occupational Safety and Health Administration (OSHA). This includes training, fit-testing, and fit-checking to ensure appropriate respirator selection and use. To be effective, respirators must provide a proper sealing surface on the wearer's face. Detailed information on a respiratory protection program is provided at this OSHA web page.

This CDC Page last modified May 21, 2004